Open AccessLetter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter]
Author(s) -
Chiara C Brück
Publication year - 2022
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s361484
Subject(s) - medicine , vascular dementia , fluoxetine , dementia , cognitive impairment , cognition , randomized controlled trial , vegf receptors , bioinformatics , psychiatry , receptor , disease , serotonin , biology